Back
Chemomab Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
54
CMMB
Chemomab Therapeutics
Last Price:
$1.31
Seasonality Move:
-1.41%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and CMMB is experiencing slight buying pressure.
Chemomab Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.37 | Sell |
| 20-day SMA: | 1.32 | Buy |
| 50-day SMA: | 1.23 | Buy |
| 200-day SMA: | 1.57 | Sell |
| 8-day EMA: | 1.35 | Sell |
| 20-day EMA: | 1.31 | Buy |
| 50-day EMA: | 1.1 | Buy |
| 200-day EMA: | 0.49 | Buy |
Chemomab Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 50.7 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.26 - 1.38) | Buy |
| Bollinger Bands (100): | (1.15 - 1.93) | Sell |
Chemomab Therapeutics Technical Analysis
| May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Chemomab Therapeutics Stock
Is Chemomab Therapeutics Stock a Buy?
-
Chemomab Therapeutics share price is 1.32 while CMMB 8-day simple moving average is 1.37, which is a Sell signal.
-
The stock price of CMMB is 1.32 while Chemomab Therapeutics 20-day SMA is 1.32, which makes it a Buy.
-
Chemomab Therapeutics 50-day simple moving average is 1.23 while CMMB share price is 1.32, making it a Buy technically.
-
CMMB stock price is 1.32 and Chemomab Therapeutics 200-day simple moving average is 1.57, creating a Sell signal.
CMMB Technical Analysis vs Fundamental Analysis
Buy
54
Chemomab Therapeutics (CMMB)
is a Buy
Is Chemomab Therapeutics a Buy or a Sell?
-
Chemomab Therapeutics stock is rated a BuyThe current Chemomab Therapeutics [CMMB] share price is $1.32. The Score for CMMB is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
Chemomab Therapeutics Stock Info
Market Cap:
24.9M
Price in USD:
1.32
Share Volume:
72.6K
Chemomab Therapeutics 52-Week Range
52-Week High:
2.55
52-Week Low:
0.78
Buy
54
Chemomab Therapeutics (CMMB)
is a Buy
Chemomab Therapeutics Share Price Forecast
-
What is the Chemomab Therapeutics stock price today?The Chemomab Therapeutics stock price is 1.32 USD today.
-
Will CMMB stock go up or go down?Chemomab Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Chemomab Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Chemomab Therapeutics is not overvalued.
Is Chemomab Therapeutics Stock a Buy?
-
Chemomab Therapeutics share price is 1.32 while CMMB 8-day exponential moving average is 1.35, which is a Sell signal.
-
The stock price of CMMB is 1.32 while Chemomab Therapeutics 20-day EMA is 1.31, which makes it a Buy.
-
Chemomab Therapeutics 50-day exponential moving average is 1.10 while CMMB share price is 1.32, making it a Buy technically.
-
CMMB stock price is 1.32 and Chemomab Therapeutics 200-day simple moving average is 0.49, creating a Buy signal.
Fundamental Analysis of Chemomab Therapeutics
Is Chemomab Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and a decrease next year of $0.01 per share.
Technical Analysis of Chemomab Therapeutics
Should I short Chemomab Therapeutics stock?
-
CMMB Moving Average Covergence Divergence (MACD) indicator is 0.06, suggesting Chemomab Therapeutics is a Buy
-
Chemomab Therapeutics Relative Strength Index (RSI) is 50.7, which suggest Chemomab Therapeutics is overbought
-
The Bollinger Bands (25) for Chemomab Therapeutics is (1.26 - 1.38), which suggest Chemomab Therapeutics is a Sell
-
The Bollinger Bands (100) for Chemomab Therapeutics is (1.15 - 1.93), which suggest Chemomab Therapeutics is a Sell
* Chemomab Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.